Pierre Lecocq - NGYX srl | 人才画像

基本信息

Career Trajectory

Bio

SRL NGYX. Consultant BioIT Biotech / Pharma / Health Care Diagnostics / Clinical Research. See Linkedin for an updated resume: https://www.linkedin.com/in/pierre-lecocq-03526721

Research Interests

Papers共 28 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparison of Drug Resistance Scores for Tipranavir in Protease Inhibitor-Naive Patients Infected with Hiv-1 B and Non-B Subtypes

Martin Stuermer,Christoph Stephan,Peter Gute,Gaby Knecht,Markus Bickel,Hans-Reinhard Brodt,Hans W. Doerr, Lutz Guertler,Pierre Lecocq,Margriet van Houtte

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2011）

Cited6Views0WOSBibtex

Cross-validated Stepwise Regression for Identification of Novel Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Associated Mutations

Koen Van der Borght,Elke Van Craenenbroeck,Pierre Lecocq,Margriet Van Houtte, Barbara Van Kerckhove,Lee Bacheler,Geert Verbeke,Herman van Vlijmen

BMC Bioinformaticsno. 1 (2011)

Cited65Views0WOSEIBibtex

Genetic diversity and complexity of drug resistance continue to increase in the reverse transcriptase and protease regions of HIV-1

H. van Vlijmen,M. Van Houtte,K. Van der Borght,P. Lecocq,L. Bacheler,P. Sista

ANTIVIRAL THERAPYno. 4.0 (2009): A82-A82

Cited0Views0Bibtex

Clinical Cut-Offs for HIV-1 Phenotypic Resistance Estimates: Update Based on Recent Pivotal Clinical Trial Data and a Revised Approach to Viral Mixtures

Bart Winters,Elke Van Craenenbroeck,Koen Van der Borght,Pierre Lecocq,Jorge Villacian,Lee Bacheler

Journal of Virological Methods（2009）

Cited20Views0WOSBibtex

Compilation and Prevalence of Mutations Associated with Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors

Lotke Tombuyzer,Hilde Azijn,Laurence T. Rimsky,Johan Vingerhoets,Pierre Lecocq,Guenter Kraus,Gaston Picchio,Marie-Pierre de Bethune

Antiviral Therapy（2009）

Cited100Views0WOSBibtex

100

A Comparison of HIV‐1 Drug Susceptibility As Provided by Conventional Phenotyping and by a Phenotype Prediction Tool Based on Viral Genotype

Margriet Van Houtte,Gaston Picchio,Koen Van der Borght,Theresa Pattery,Pierre Lecocq,Lee T. Bacheler

Journal of Medical Virology（2009）

Cited33Views0WOSBibtex

Short communication Compilation and prevalence of mutations associated with resistance to non-nucleoside

Lotke Tambuyzer,Hilde Azijn,Laurence T Rimsky,Johan Vingerhoets,Pierre Lecocq,Guenter Kraus,Gaston Picchio,Marie-Pierre de Béthune

semanticscholar（2009）

Cited0Views0Bibtex

Silent Mutations Are Selected in HIV-1 Reverse Transcriptase and Affect Enzymatic Efficiency

P. Richard Harrigan,Chih-Wei Sheen,Vikram S. Gill,Brian Wynhoven,Erin Hudson,Viviane D. Lima,Pierre Lecocq,Rosalia Aguirre,Art F. Y. Poon,Nicolas Sluis-Cremer

AIDS（2008）

Cited20Views0WOSBibtex

The HIV-1 Protease Resistance Mutation I50L is Associated with Resistance to Atazanavir and Susceptibility to Other Protease Inhibitors in Multiple Mutational Contexts

P. Sista,B. Wasikowski,P. Lecocq,T. Pattery,L. Bacheler

Journal of Clinical Virology（2008）

Cited18Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn